Cargando…

In Vitro Antimetastatic Effect of Phosphatidylinositol 3-Kinase Inhibitor ZSTK474 on Prostate Cancer PC3 Cells

Tumor metastasis is the main cause of lethality of prostate cancer, because conventional therapies like surgery and hormone treatment rarely work at this stage. Tumor cell migration, invasion and adhesion are necessary processes for metastasis. By providing nutrition and an escape route from the pri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wennan, Guo, Wenzhi, Zhou, Qianxiang, Ma, Sheng-Nan, Wang, Ran, Qiu, Yuling, Jin, Meihua, Duan, Hong-Quan, Kong, Dexin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742204/ https://www.ncbi.nlm.nih.gov/pubmed/23812078 http://dx.doi.org/10.3390/ijms140713577

Ejemplares similares

In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells
por: Zhou, Qianxiang, et al.
Publicado: (2016)

ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells
por: Wang, Yaochen, et al.
Publicado: (2016)

Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells
por: Zhou, Qianxiang, et al.
Publicado: (2017)

ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair
por: Jiao, Wenhui, et al.
Publicado: (2022)

Proteomic analysis of phosphoproteins sensitive to a phosphatidylinositol 3-kinase inhibitor, ZSTK474, by using SELDI-TOF MS
por: Akashi, Tetsuyuki, et al.
Publicado: (2009)

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)
por: LIN, LEHANG, et al.
Publicado: (2013)

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
por: Zhao, Wennan, et al.
Publicado: (2017)

Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474
por: Isoyama, Sho, et al.
Publicado: (2015)

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
por: Namatame, Nachi, et al.
Publicado: (2018)

Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice
por: Toyama, Shoko, et al.
Publicado: (2010)

Class I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion injury
por: Wang, Po, et al.
Publicado: (2016)

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells
por: Bertazza, Loris, et al.
Publicado: (2015)

Inhibitory Activity of Flavonoids against Class I Phosphatidylinositol 3-Kinase Isoforms
por: Kong, Dexin, et al.
Publicado: (2011)

The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
por: Jiang, Jinqiong, et al.
Publicado: (2021)

Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5
por: Chen, Yali, et al.
Publicado: (2017)

Antiproliferative Effect of Aaptamine on Human Chronic Myeloid Leukemia K562 Cells
por: Jin, Meihua, et al.
Publicado: (2011)

In Vitro Antitumor Activity of Stellettin B, a Triterpene from Marine Sponge Jaspis stellifera, on Human Glioblastoma Cancer SF295 Cells
por: Tang, Sheng-An, et al.
Publicado: (2014)

Terminamines K–S, Antimetastatic Pregnane Alkaloids from the Whole Herb of Pachysandra terminalis
por: Li, Xiang-Yu, et al.
Publicado: (2016)

Phosphatidylinositol 3 kinase modulation of trophoblast cell differentiation
por: Kent, Lindsey N, et al.
Publicado: (2010)

Architecture and dynamics of the autophagic phosphatidylinositol 3-kinase complex
por: Baskaran, Sulochanadevi, et al.
Publicado: (2014)

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome
por: Cohen, Jeffrey I.
Publicado: (2018)

Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia
por: Goncalves, Marcus D., et al.
Publicado: (2022)

CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells
Publicado: (1995)

The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer
por: Chu, Chien-An, et al.
Publicado: (2021)

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013)

PI3 kinase directly phosphorylates Akt1/2 at Ser473/474 in the insulin signal transduction pathway
por: Tsuchiya, A, et al.
Publicado: (2014)

Autophagy Restricts Proliferation Driven By Oncogenic Phosphatidylinositol 3-Kinase in Three-Dimensional Culture
por: Chen, Nan, et al.
Publicado: (2012)

Phosphatidylinositol 3-Kinase Is a Negative Regulator of Cellular Differentiation
por: Ptasznik, Andrzej, et al.
Publicado: (1997)

Multiple Phosphatidylinositol 3-Kinases Regulate Vaccinia Virus Morphogenesis
por: McNulty, Shannon, et al.
Publicado: (2010)

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
por: Brana, Irene, et al.
Publicado: (2012)

Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking
por: Yoshioka, Kazuaki
Publicado: (2021)

Effective models for antimetastatic therapies
por: Tian, Lin, et al.
Publicado: (2017)

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
por: Knowles, Margaret A., et al.
Publicado: (2009)

Antimetastatic activity of novel ruthenium (III) pyridine complexes
por: Gu, Liwei, et al.
Publicado: (2016)

Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons
por: Philpott, Karen L., et al.
Publicado: (1997)

Regulation of the Target of Rapamycin and Other Phosphatidylinositol 3-Kinase-Related Kinases by Membrane Targeting
por: De Cicco, Maristella, et al.
Publicado: (2015)

Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
por: Adamo, Barbara, et al.
Publicado: (2011)

Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma
por: Fang, Xiaosheng, et al.
Publicado: (2013)

Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
por: Castillo, Jorge J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p8cnkbkmfhkua163ij0kquqm8f